Software Refraction With Mobilerone Versus Retinoscopy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Software Refraction With Mobilerone Versus Retinoscopy — Stella

Recruiting

Back to Myopia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

China

Airdoc MPC Opthalmology Clinics, Beijing, Beijing Municipality

Jenny QIU, Beijing, Beijing Municipality

Qiu Jenny, Beijing, Haidian District

Key details

Sponsor

Beijing Airdoc Technology Co., Ltd.

Collaborators

University of Notre Dame Australia

Enrollment target

~120 participants

Started

July 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

10 Years – 46 Years

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov